ArticleCureus2025
Sodergren Hemorrhoidal Symptom Severity Score as a Guide for Treatment of Hemorrhoidal Disease: A Cross-Sectional Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objectives Hemorrhoidal disease (HD) is a common anorectal condition affecting a large number of adults worldwide. Lack of standardized outcomes limits treatment decisions in HD. Patient-reported outcome measures (PROMs), directly reported by the patients, offer standardized, patient-centric measures, aiding in HD severity assessment and treatment decisions. The Sodergren score is one such PROM that has shown significant predictive ability for surgical decision-making in HD patients. The Aim of this study was to find a Sodergren hemorrhoidal symptom severity cut-off score to predict the need for surgical management in hemorrhoidal disease. Methodology All patients > 18 years of age diagnosed with HD presenting to the outpatient clinics in the Colorectal Unit, who gave their consent to participate, were included in the study. Patients with anal fistula, anal fissure, inflammatory bowel disease (IBD), colorectal malignancy, prior hemorrhoidal surgery, on antiplatelet therapy, and pregnancy were excluded. The sample size calculated was 34. Based on the treatment, the patients were divided into non-surgical (A) and surgical (B) groups (17 in each group). The patients were made to fill out the Sodergren hemorrhoidal symptom severity score questionnaire. The final Sodergren score was recorded for data analysis. Results Sodergren score was evaluated in 34 HD patients; 17 in each treatment group. A significant difference in Sodergren scores was found between the non-surgical group (median: 4; interquartile range (IQR) 0-4 ) and the surgical treatment group (median: 7 (IQR 4-10) (P=0.001). The Sodergren score demonstrated an area under the receiver operating characteristic curve (AUC) of 0.834 (95% CI: 0.702 - 0.966) for predicting surgical decision-making, with an optimal cut-off score of ≥7 (sensitivity:58.8; specificity:88.2). Conclusion Sodergren score demonstrated utility as a patient-reported severity assessment tool to guide treatment outcomes in HD patients. A cut-off score of ≥7 was predictive of surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.